Skip to main content

Table 2 Oocyte yields in 1st - 3rd cycles among patients who completed three cycles of treatment with < or ≥120 days interval between cycles

From: Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study

 

N

Cycles of treatment

P (linear trend)

1st cycle

2nd cycle

3rd cycle

Group 1 - Time < 120 days

Age (years)

68

40.2 ± 4.4

40.4 ± 4.3

40.5 ± 4.3

0.001

FSH Dose (units)

68

6519 ± 2202

6486 ± 2344

7381 ± 2355

0.05

No Oocytes

68

23 (33.8)a

17 (25.0)

11 (16.2)a

0.024

Oocyte (total)

68

2.81 (2.02 - 3.60)b,c

3.84 (2.88 - 4.80)b

4.50 (3.48 - 5.53)c

0.001

Embryos transferred

68

1.10 (0.78-1.42)b

1.37 (0.99-1.74)

1.59 (1.2-1.95)b

0.004

Cancelled Cycles

68

32.4% (23–42)d

18% (8–27)

13% (4–23)d

0.006

Group 2 - Time ≥ 120 days

Age (years)

17

41.6 ± 3.2

42.2 ± 3.0

42.5 ± 3.2

0.001

FSH Dose (units)

17

6965 ± 2712

6520 ± 2288

5070 ± 2714

0.08

No Oocytes

17

2 (11.8)

4 (23.5)

5 (29.4)

0.22

Oocyte (total)

17

4.35 (2.78 – 5.92)

3.35 (1.78 - 4.93)

2.77 (1.19 – 4.33)

0.185

Embryos transferred

17

1.24 (0.62-1.85)

1.06 (0.44-1.67)

0.82 (0.21-1.44)

0.60

Cancelled Cycles

17

0

0

18% (7–29)

0.028

  1. Values are presented as means (95% confidence intervals) or ± standard deviation.
  2. ap = 0.03; bp = 0.003; cp = 0.001; dp = 0.018.